日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Molecular characterization of a new R1925X point mutation mouse model for dysferlinopathy

对一种新的R1925X点突变小鼠模型进行分子表征,该模型与dysferlin病相关。

Bouchard, Camille; Despax, Louis; Rousseau, Joël; Tremblay, Jacques P

Universal Prime Editing Therapeutic Strategy for RyR1-Related Myopathies: A Protective Mutation Rescues Leaky RyR1 Channel

针对 RyR1 相关肌病的通用型 Prime 编辑治疗策略:一种保护性突变可挽救 RyR1 通道的渗漏

Godbout, Kelly; Dugas, Mathieu; Reiken, Steven R; Ramezani, Sina; Falle, Alexia; Rousseau, Joël; Wronska, Anetta E; Lamothe, Gabriel; Canet, Geoffrey; Lu, Yaoyao; Planel, Emmanuel; Marks, Andrew R; Tremblay, Jacques P

In Vitro Correction of Point Mutations in the DYSF Gene Using Prime Editing

利用先导编辑技术体外校正DYSF基因中的点突变

Bouchard, Camille; Rousseau, Joël; Lamothe, Gabriel; Dubost, Marie; Bastrenta, Laura; Ramezani, Sina; Tremblay, Jacques P

Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada

在加拿大魁北克省,充分利用细胞疗法、基因疗法和再生医学的潜力。

Delisle, Jean-Sébastien; Fournier, Diane; Santerre, Kim; Rochette, Samuel; Zawati, Ma'n H; Dumont-Lagacé, Maude; Turcotte, Simon; Guertin, Jason Robert; Vermette, Patrick; Tremblay, Jacques P; Parisotto, Maxime; Beauséjour, Christian; Gélinas, Jean-François; Petropoulos, Louisa; Kekre, Natasha; Michaud, Stéphanie; Dieudé, Mélanie

Correction: Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada

更正:加拿大魁北克省正在利用细胞疗法、基因疗法和再生医学的潜力

Delisle, Jean-Sébastien; Fournier, Diane; Santerre, Kim; Rochette, Samuel; Zawati, Ma'n H; Dumont-Lagacé, Maude; Turcotte, Simon; Guertin, Jason Robert; Vermette, Patrick; Tremblay, Jacques P; Parisotto, Maxime; Beauséjour, Christian; Gélinas, Jean-François; Petropoulos, Louisa; Kekre, Natasha; Michaud, Stéphanie; Dieudé, Mélanie

Emerging Perspectives on Prime Editor Delivery to the Brain

关于大脑主要编辑传递的新观点

BenDavid, Eli; Ramezanian, Sina; Lu, Yaoyao; Rousseau, Joël; Schroeder, Avi; Lavertu, Marc; Tremblay, Jacques P

CRISPR-Cas9 delivery strategies with engineered extracellular vesicles

利用工程化细胞外囊泡的CRISPR-Cas9递送策略

Lu, Yaoyao; Godbout, Kelly; Lamothe, Gabriel; Tremblay, Jacques P

Successful Correction by Prime Editing of a Mutation in the RYR1 Gene Responsible for a Myopathy

通过基因编辑成功纠正了导致肌病的RYR1基因突变。

Godbout, Kelly; Rousseau, Joël; Tremblay, Jacques P

Prime Editing for Human Gene Therapy: Where Are We Now?

人类基因治疗中的精准编辑:我们现在处于什么阶段?

Godbout, Kelly; Tremblay, Jacques P

Limb-Girdle Muscular Dystrophies Classification and Therapies

肢带型肌营养不良症的分类和治疗

Bouchard, Camille; Tremblay, Jacques P